Comparison of enterobacteriaceae antibiotic resistance pattern isolated from hospital admitted patients and outpatients urine culture

authors:

avatar Ali Jazayeri Moghadas , * , avatar Soheil Kasaian naeeni , avatar Naemeh sadat Kia , avatar ali jazayeri moghadas


how to cite: Jazayeri Moghadas A, Kasaian naeeni S, Kia N S, jazayeri moghadas A. Comparison of enterobacteriaceae antibiotic resistance pattern isolated from hospital admitted patients and outpatients urine culture. koomesh. 2019;21(3):e153097. 

Abstract

Introduction: Urinary tract infection (UTI) is one of the most common infections and Enterobacteriaceae members are the most common bacterial agent of this infection. Antibiotic susceptibility pattern identification is necessary for complete treatment. In this way, this study was accomplished to compare the enterobacteriaceae antibiotic resistance pattern of UTI patients. Materials and Methods: This study including two groups of 78 patients as outpatients and admitted ones. UTI was diagnosed by urine culture and colony count. Antibiotic susceptibility test performed according to CLSI guidelines. Results: E. coli was recognized as the most frequent bacterial agent in both outpatients (66.7%) and admitted (82.1%) groups, while klebsiella spp. caused UTI in 16.7% of admitted patients and 32.1% of outpatients. The most antibiotic resistance was observed to Cefazolin (85.9%) and Nalidixic acid (78.1%) in outpatients and admitted respectively. Conclusion: Resistance to cefazolin in outpatients was significantly more than admitted patients, while resistance to amikacin, ciprofloxacin, nalidixic acid, ceftriaxone, cefotaxime, and gentamycin in admitted patients was significantly more than outpatients. Conspiciously, the resistance rate to ciprofloxacin, nalidixic and cefixime significantly increased in comparison with a similar study in Semnan (Ian), 2000.  The differences in antibiotic resistance pattern must be notified in outpatients and admitted patients, in order to better antibiotic prescription

References

  • 1.

    Mims CA, Dockrell HM, Goering RV. Medical Microbiology. 3rd ed. London: Mosby CO: 2004.

  • 2.

    Foxman B. Epidemiology of urinary tract infection: incidence, morbidity, and economic cost. Dis Mon 2003; 49: 53-70.

  • 3.

    Cunha CB. The Pharmacoeconomic Aspects of Antibiotic Stewardship Programs. Med Clin North Am 2018; 102: 937-946.

  • 4.

    Connie R. Mahon, Donald C. Lehman, George Manuselis. Textbook of diagnostic microbiology. Saunders/Elsevier 2011.

  • 5.

    Chinen I, Tanaro JD, Miliwebsky E, Lound LH, Chillemi G, Ledri S, et al. Isolation and characterization of Escherichia coli O157:H7 from retail meats in Argentina. J Food Prot 2001; 64: 1346-1351.

  • 6.

    N. Cary Engleberg, Terence Dermody, Victor DiRita. Schaechter's Mechanisms of Microbial Disease 5th Edition. Wolters Kluwer Health. 2014.

  • 7.

    Richard A. McPherson, Matthew R. Pincus. Henry's Clinical Diagnosis and Management by Laboratory Methods. Elsevier Health Sciences. 2011.

  • 8.

    Li XZ, Plsiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 2015; 28: 337-418.

  • 9.

    National kidney foundation, New Studies offer hope to UTI Suffers, http://www .kidney.org/ general/news/newstudy.cfm.

  • 10.

    Prado V, Zervas A. Profile of antimicrobial resistance of agent causing UTI in children. Rtu Med Child 2001; 129: 877.

  • 11.

    Manvselis M. Text book of diagnostic microbiology SAUNDERS. 2000.

  • 12.

    Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999; 14: 606-609.

  • 13.

    Hackette, Urinary tract infection, http://www.Netdoctor.co.Uk/menshealth/fcects/urinaryinfection.htm.

  • 14.

    Sahm DF, Thorns berry C, Mayfield DC, Jones Mark E, Karlowsky James A. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics inthe United States in 2000. Antimicrob Agents Chemother 2001; 45: 1402-1406.

  • 15.

    Pechre JC, Micha-Hamzhepour M, Khler T. Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa. Bull Acad Natl Med 1998; 182: 599-612.

  • 16.

    Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999; 58: 11-18.

  • 17.

    Tanaka M, Onodera Y, Uchida Y, Sato K, Hayakawa I. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob Agents Chemother 1997; 41: 2362-2366.

  • 18.

    Fauci A, Longo D, Braunwald E, editors. Harrisons principles of internal medicine. 17th ed. USA: McGrawHill 2008; 858.

  • 19.

    Haller M, Brandis M, Berner R. Antibiotics resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 2004; 19: 982-986.

  • 20.

    Forbes, Betty A, and Tille, Patricia M. Bailey & Scott's diagnostic microbiology. 14th ed. Elsevier; 2018.

  • 21.

    Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.

  • 22.

    John E. Bennett, Raphael Dolin, Martin J. Blaser. Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases.8th ed. Elsevier 2015.

  • 23.

    Jazayeri Moghadas A. Frequency of the bacterial agents in urinary tract infection and their antibiotic susceptibility pattern in Semnan. Koomesh 2000; 4: 16-11.

  • 24.

    Odongo CO, Anywar D, Odongo P. Antibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study. BMC Infect Dis 2013;13: 193.

  • 25.

    Lafi S A,Alkarboly AA, Lafi A. Bacterial urinary tract infection in adults, Hit district Anbar governorate, west of Iraq. Egypt. Acad J Biolog Sci 2012; 4: 21-26.

  • 26.

    Kibret M, Abera B. Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie Health Research Laboratory, Ethiopia. Asian Pac J Trop Biomed 2014; 4: 164-168.

  • 27.

    Molaabaszadeh H, Hajisheikhzadeh B, Mollazadeh M, Eslami K, Mohammadzadeh Gheshlaghi N. The study of sensibility and antimicrobial resistance in escherichia coli isolated from urinary tract infection in Tabriz city. J Fasa Univ Med Sci 2013; 3: 149-154. (Persian).

  • 28.

    Asghari A. Review of antibiotics sensivity of Ecoli isolated from urine culture of patient in Mazandaran state. Exper Anim Biol J 2012; 3: 13-25. (Persian).

  • 29.

    Hamid Farahani R, Tajik AR, Noorifard M, Keshavarz A, Taghavipour N, Hossieni Shokouh J. Antibitic resistance pattern of E.coli isolated from urine culture in 660 army clinical laboratory center in Tehran 2008. Ann Military Health Sci Res J 2012; 10: 45-49. (Persian).

  • 30.

    Noor AF, Shams F, Munshi SK, Hassan M, Noor R. Prevalence and and antibiogram profile of uropathogens isolated from hospital and community patients with urinary tract infections in Dhaka city. J Bangladesh Acad Sci 2013; 37: 57-63.

  • 31.

    Beheshti F, Rahmati A, and Akhi M. Compression of minimum inhibitory concentration of common antibiotics effect on E.coli isolation from urine culture of outpatient and inpatient. Med J Tabriz Univ Med Sci 2005; 27: 27-31. (Persian).

  • 32.

    Sabzevari S. Review of antibiotics resistance of gram negative bacteria isolated from urine culture of Emamreza hospital outpatient. PHD thesis. Mashhad Med Univ 2004. (Persian).